CV Lattes
Universidade de São Paulo (USP). Faculdade de Medicina (FM) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Currently a doctoral student in the Experimental Pathophysiology program at the Faculty of Medicine of the University of São Paulo - FMUSP and a member of the Health Service Waste Generation Commission, linked to the board of LIMs of HC-FMUSP. Bachelor of Biotechnology from the Federal University of São Carlos-campus Araras / SP (2012) and Master of Science from the Chemical Biology Program of the Federal University of São Paulo - UNIFESP. Was involved with the development of DNA vaccines against Leishmaniasis at the Faculty of Medicine of the University of São Paulo - FMUSP. Experience in the area of Immunology and Parasitology, with an emphasis on Parasitic Protozoology and cellular immune response. Held part of his doctorate at the Faculty of Pharmacy of the University of Porto in Portugal, where he had experience with lipid nanocarriers. It works mainly in parasitic biology, therapeutic combination, evaluation of natural compounds against cutaneous and visceral Leishmaniasis and targeted drug delivery through solid lipid nanoparticles and nanostructured lipid carriers. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Leishmaniasis are antropozoonosis considered as a serious problem of public health, that represent a complex of diseases with important clinical spectrum and epidemiological diversity. The current treatments are not totally effective and possess serious side effects to patients. Furthermore, in some parts of the world there are reports of resistance of the parasite to standard drugs, that…
Visceral leishmaniasis or calazar is a serious chronic disease, potentially fatal to humans, in which mortality can reach 10% when not establishing proper treatment, which is based on antimony, and in cases where there is a failure of antimonials, amphotericin B is employed. Both drugs have a number of local and systemic side effects. Also, some reports show that there is the emergence o…
The antigens released by parasites are interesting targets for the development of vaccine candidates, as are the first molecules to interact with the innate immune system and establish an intrinsic physiological interaction with the host cell. Therefore, these antigens have been targets for the development of vaccines against cutaneous leishmaniasis, visceral canine, and murine, respectiv…
(Only some records are available in English at this moment)
Leishmaniasis is endemic in 98 countries and it is considered neglected by the World Health Organization. Leishmaniasis is caused by a protozoan parasite of the Leishmania genus and is transmitted by a sandfly vector. This disease presents different clinical forms, ranging from simple ulcerated skin lesion, that may disappears spontaneously, to the visceral form that affects internal orga…
| 4 / 4 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 5 / 5 | All Scholarships |
| Associated processes | |